MWM
CLRB icon

Modera Wealth Management’s Cellectar Biosciences CLRB Stock Holding History

Modera Wealth Management’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-67
Closed -$8K – 320
2022
Q2 		$8K Hold
67
– – ﹤0.01% 333
2022
Q1 		$14K Hold
67
– – ﹤0.01% 352
2021
Q4 		$13K Hold
67
– – ﹤0.01% 599
2021
Q3 		$19K Buy
+67
New +$20.4K ﹤0.01% 275
2021
Q1 		– Sell
-33
Closed -$21K – 231
2020
Q4 		$21K Buy
+33
New +$15.2K ﹤0.01% 240

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Modera Wealth Management's CLRB Position: Q3 2022 in Review

Modera Wealth Management sold out of Cellectar Biosciences (CLRB) in Q3 2022, closing a stake of 67 shares — an estimated $8K sold.

Modera Wealth Management first reported a position in CLRB in Q4 2020 and held it in 5 quarters. The position peaked at $21K in Q4 2020. 20 funds tracked by Wall St. Rank hold CLRB as of Q3 2022.

  • Modera Wealth Management reported no remaining Cellectar Biosciences position as of Q3 2022 after selling out during the quarter.
  • Modera Wealth Management sold 67 Cellectar Biosciences shares in Q3 2022, an estimated $8K.
  • Modera Wealth Management first reported a position in Cellectar Biosciences in Q4 2020 and held it in 5 quarters.
  • Modera Wealth Management's Cellectar Biosciences position peaked at $21K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2022.

Based on Modera Wealth Management's 13F filing for Q3 2022, filed 1 Nov 2022.